Drugs Controller General of India
GPTKB entity
Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
government position
|
| gptkbp:advocacy |
drug safety
|
| gptkbp:advocatesFor |
public health
|
| gptkbp:aimsTo |
drug accessibility
|
| gptkbp:broadcasts |
unsafe drugs
|
| gptkbp:collaborates_with |
other regulatory bodies
|
| gptkbp:compatibleWith |
drug safety standards
drug laws |
| gptkbp:coordinatesWith |
international health organizations
state drug authorities |
| gptkbp:engagesIn |
stakeholders in healthcare
|
| gptkbp:evaluates |
pharmaceutical companies
|
| gptkbp:handles |
adverse drug reactions
|
| gptkbp:has_a_role_in |
pharmacovigilance
|
| https://www.w3.org/2000/01/rdf-schema#label |
Drugs Controller General of India
|
| gptkbp:is_a_key_player_in |
healthcare_innovation.
|
| gptkbp:is_a_member_of |
national health committees
|
| gptkbp:is_available_in |
essential medicines
|
| gptkbp:is_involved_in |
drug safety initiatives
drug policy formulation drug supply chain management healthcare_reforms |
| gptkbp:is_part_of |
gptkb:Central_Drugs_Standard_Control_Organization
|
| gptkbp:is_tasked_with |
ensuring drug efficacy
|
| gptkbp:issuedBy |
Government of India
|
| gptkbp:issueFeePaid |
drug pricing
drug market trends |
| gptkbp:key_figure |
public health policy
|
| gptkbp:manages |
drug recalls
|
| gptkbp:monitors |
drug quality
|
| gptkbp:notableFeature |
drug approval process
|
| gptkbp:oversees |
drug regulation
|
| gptkbp:participatesIn |
drug safety assessments
international drug regulation forums |
| gptkbp:promotes |
rational use of drugs
|
| gptkbp:provides |
clinical trials
drug testing pharmaceutical research drug manufacturing drug advertising |
| gptkbp:provides_access_to |
medicines
|
| gptkbp:providesTrainingFor |
drug regulation
|
| gptkbp:regulates |
clinical research
biological products |
| gptkbp:reportsTo |
gptkb:Ministry_of_Health_and_Family_Welfare
|
| gptkbp:research_focus |
new therapies
pharmaceutical sciences |
| gptkbp:responsibleFor |
drug labeling regulations
drug import regulations approving new drugs |
| gptkbp:reviews |
new drug registrations
|
| gptkbp:suitableFor |
drug legislation
|
| gptkbp:visibility |
drug approval process
|
| gptkbp:works_with |
medical professionals
improving healthcare access |